Ratutrelvir
Ratutrelvir is a NF-κB p65 inhibitor. Ratutrelvir blocks the translocation of NF-κB p65 from the cytoplasm to the nucleus, reduces the phosphorylation levels of NF-κB p65 and IκBα, and inhibits the DNA-binding activity of NF-κB p65. Ratutrelvir inhibits the migration and invasion abilities of breast cancer cells, and reduces their viability and colony-forming capacity. Ratutrelvir can be used for the research of luminal A breast cancer.
연구목적의 판매만을 진행합니다. 환자를 대상으로 한 판매는 하지 않습니다.
- CAS No.: 2929236-94-0
- 화학식: C27H32F3N5O4
- 분자량:547.57
-
보관:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
제품 설명
In Vitro
Ratutrelvir (0-100 μM; 24-96 h) potently reduces the viability of MCF-7 cells, with an IC50 of 53.9 μM; it only exerts weak inhibitory effects on MDA-MB-231 and MCF-10A cells at high concentrations, and shows no inhibitory effect on the viability of BT474 cells[1].
Ratutrelvir (0-100 μM; 48 h) inhibits colony formation of MCF-7 cells in a concentration-dependent manner, suppresses colony formation of MDA-MB-231 cells at a concentration of 50 μM, and exerts no effect on colony formation of BT474 cells[1].
Ratutrelvir (25 μM; 48 h) significantly inhibits the migration of MCF-7 cells, but exerts no effect on the migration of MDA-MB-231 or BT474 cells[1].
Ratutrelvir (12.5 μM; 72 h) significantly reduces the invasive ability of MCF-7 cells, but exerts no effect on the invasive ability of MDA-MB-231 or BT474 cells[1].
Ratutrelvir (0-100 μM; 12 h) inhibits the NF-κB pathway in MCF-7 cells by reducing the levels of p-NF-κB p65 and p-IκBα and blocking the nuclear translocation of NF-κB p65, but exerts no effect on the NF-κB pathway in MDA-MB-231 or BT474 cells[1].
Ratutrelvir (50 μM; 2, 4, 6, 8, 12 h) inhibits the DNA-binding activity of NF-κB in MCF-7 cells in a time-dependent manner in vitro, but exerts no effect on this activity in MDA-MB-231 or BT474 cells[1].
Ratutrelvir (0-100 μM; 96 h) inhibits TNF-α-mediated NF-κB activation in MCF-7 cells, and TNF-α can partially reverse the inhibitory effects of Ratutrelvir on the proliferation, migration and invasion of MCF-7 cells[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:Human MCF-7, MDA-MB-231, BT474, and MCF-10A breast cells
-
Concentration:0, 12.5, 25, 50, 75, 100 μM
-
Incubation Time:24, 48, 96 h
-
Result:Reduced MCF-7 cell viability in a concentration- and time-dependent manner, with an IC50 of 53.9 μM.
Showed a slight inhibitory effect on MDA-MB-231 cells at 75 μM.
Showed no inhibitory effect on BT474 cells at up to 100 μM.
Inhibited MCF-10A cell proliferation only at 75 μM, and this effect was significantly weaker than that on MCF-7 cells.
-
Cell Line:Human MCF-7, MDA-MB-231, and BT474 breast cancer cells
-
Concentration:0, 12.5, 25, 50, 75, 100 μM
-
Incubation Time:48 h
-
Result:Reduced the percentage of surviving MCF-7 cell colonies in a concentration-dependent manner.
Reduced MDA-MB-231 colony formation at 50 μM.
Showed no effect on BT474 colony formation.
-
Cell Line:Human MCF-7, MDA-MB-231, and BT474 breast cancer cells
-
Concentration:25 μM
-
Incubation Time:48 h
-
Result:Significantly inhibited the migration of MCF-7 cells.
Did not suppress the migration of MDA-MB-231 or BT474 cells.
-
Cell Line:Human MCF-7, MDA-MB-231, and BT474 breast cancer cells
-
Concentration:12.5 μM
-
Incubation Time:72 h
-
Result:Significantly reduced the invasiveness of MCF-7 cells.
Did not significantly affect the invasiveness of MDA-MB-231 or BT474 cells.
-
Cell Line:Human MCF-7, MDA-MB-231, and BT474 breast cancer cells
-
Concentration:0, 25, 50, 75,100 μM (whole-cell lysates); 50 μM (nuclear/cytoplasmic fractionation)
-
Incubation Time:12 h
-
Result:Decreased the expression of p-NF-κB p65 and p-IκBα in a concentration-dependent manner in MCF-7 cells, while NF-κB p65 and IκBα protein levels were not markedly altered.
Notably suppressed the nuclear localization of NF-κB p65 in MCF-7 cells.
Did not alter the levels of p-NF-κB p65, p-IκBα, NF-κB p65, or IκBα in MDA-MB-231 and BT474 cells.
Chemical Information
-
CAS No. 2929236-94-0
-
분자량 547.57
-
화학식 C27H32F3N5O4
-
SMILES
CC1(C)[C@](CN2C([C@H](C(C)(C)C)NC(C(F)(F)F)=O)=O)([H])[C@@]1([H])[C@H]2C(N[C@@H](CC3C(NC4=CC=CC=C43)=O)C#N)=O
-
Synonyms
TRX01
-
선적
Room temperature in continental US; may vary elsewhere.
-
보관
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocol
-
Kinase activity and phosphorylation assays
Kinase activity assays measure the ability of kinases to transfer phosphate groups from ATP to specific substrates, while phosphorylation assays detect the presence and levels of phosphorylated proteins. Common methods include radiolabeled ATP incorporation (e. g. ,), ADP release detection via bioluminescence (e. g. ,[3]), enzyme-linked immunosorbent assays (ELISA) for phospho-specific epitopes (e. g. ,[6]), and microtiter-based formats for high-throughput screening (e. g. ,[8]). The ADP-Glo assay quantifies kinase activity by measuring ADP produced during phosphorylation using a luciferase-based system. Radiometric assays involve autoradiography or scintillation counting after incorporation of 32P-labeled ATP into substrate proteins. ELISA-based approaches rely on phospho-specific antibodies to detect activated kinases in cell lysates or purified samples.
-
Western Blot
Western blotting (WB) is a commonly used experimental method in molecular biology, biochemistry, and immunogenetics for identifying and quantifying target proteins. It combines gel electrophoresis with immunoassay, enabling researchers to analyze protein expression, post-translational modifications, and molecular weight.
-
Cell migration
Cell migration is a method that plays an important role in wound healing, cell differentiation, embryonic development, etc.
-
Cell invasion
Cell invasion is the ability of cells to migrate from one area to another via the extracellular matrix. Cell invasion is the response of normal and cancer cells to chemical and mechanical stimuli. Before migrating to a new region, the extracellular matrix is degraded by proteases within the cell. Cell invasion often occurs during wound repair, vascularization and inflammation, abnormal tissue invasion, and tumor cell metastasis.
-
Research Protocol for Inflammation-related Diseases
The NLRP3 inflammasome is a cytosolic innate immune signaling platform that integrates priming signals and danger-signal activation to promote caspase-1 activation, maturation of IL-1β and IL-18, and gasdermin D-mediated pyroptotic cell death. The core experimental logic is to determine whether inflammatory disease phenotypes are driven by increased NLRP3 expression, ASC-containing inflammasome assembly, caspase-1 cleavage, GSDMD cleavage, and extracellular release of IL-1β/IL-18 rather than by nonspecific cell injury alone. The pathway is strongly linked to inflammation-related disease phenotypes because monosodium urate crystals activate NALP3/NLRP3 inflammasome signaling in gout-like crystal inflammation, cholesterol crystals activate NLRP3 inflammasomes in atherogenesis models, and DSS-induced intestinal inflammation has been reported to involve NLRP3 inflammasome activity. However, experimental colitis studies also show context-dependent protective effects of NLRP3 inflammasome co
-
Protocol for Kinase activity and phosphorylation assays
Kinase activity assays measure transfer of phosphate from ATP to a protein or peptide substrate, generating phosphorylated substrate, ADP, or incorporated radiolabeled phosphate as the readout; phosphorylation assays measure site-specific phosphorylation in cells or tissues as a proxy for kinase-pathway activation, inhibition, or substrate regulation. Phosphorylation can be detected by phospho-specific Western blot, immunoprecipitation kinase assay, phospho-immunofluorescence, phospho-flow cytometry, luminescent ADP detection, radiolabeled ATP incorporation, or reporter-based pathway assays, and these readouts can be applied to cancer cells, primary neurons, mouse tumors, organoids, inflammatory macrophages, ferroptosis studies, and mitophagy studies when the kinase target is biologically relevant.
-
Breast Cancer Modeling
Breast cancer is a heterogeneous cancer, and it has been distinguished into four subtypes: luminal A, luminal B, HER2-positive and basal-like. Molecular mutations, epigenetic alterations, hormone exposure and immune microenvironment are related to the progression of breast cancer.
-
Cell Viability Determination by MTT Colorimetric Assay
The following protocol uses the MTT colorimetric assay as a classic literature-established method for assessing cell viability/metabolic activity in cultured mammalian cells. MTT[3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] is reduced by metabolically active cells to a colored formazan product; the amount of formazan is quantified spectrophotometrically and provides an indirect measure of metabolically active viable cells. Importantly, MTT reduction reflects cellular oxidoreductase/metabolic activity rather than an absolute direct count of living cells, so changes in cellular metabolism can alter the signal independently of cell number.
순도&문서
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)